Screening Strategies in Gastrointestinal Cancer

References

• Rosenstock E, Farmer R G, Petras R, et al. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 1985; 89: 1342–1346
   PubMed Web of Science ®Google Scholar
• Nugent F W, Haggitt R C, Colcher H, Kutteruf GC. Malignant potential of chronic ulcerative colitis. Preliminary report. Gastroenterology 1979; 26: 1–5
   Google Scholar
• Nugent F W, Haggitt RC. Cancer in ulcerative colitis: results of a 13 year prospective biopsy surveillance program. Gastroenterology 1988; 94: A327
   Google Scholar
• Granqvist S, Gabrielsson N, Sundelin P, Thor-Geirsson T. Precancerous lesions in the mucosa in ulcerative colitis. Scand J Gastroenterol 1980; 15: 289–296
   PubMed Web of Science ®Google Scholar
• Dickinson R J, Dixon H F, Axon A TR. Colonoscopy and the detection of dysplasia in patients with longstanding ulcerative colitis. Lancet 1980; 2: 620–622
   PubMed Web of Science ®Google Scholar
• Lennard-Jones J E, Morson B C, Ritchie J K, Williams CB. Cancer surveillance in ulcerative colitis. Lancet 1983; 2: 149–152
   PubMed Web of Science ®Google Scholar
• Manning A P, Bulgim O R, Dixon M F, Axon A TR. Screening by colonoscopy for colonic epithelial dysplasia in inflammatory bowel disease. Gut 1987; 28: 1489–1494
   PubMedGoogle Scholar
• Lashner B A, Hanauer S B, Silverstein MC. Optimal timing for colonoscopy to screen for cancer in ulcerative colitis. Ann Intern Med 1988; 108: 274–278
   PubMed Web of Science ®Google Scholar
• Melville D M, Lennard-Jones J E, Morson B C, Ritchie J K, Williams CB. Surveillance in extensive ulcerative colitis improves prognosis without always preventing cancer. Gut 1988; 29: A1494
   Google Scholar
• Rutegard J, Ahsgren L, Sterling R, Janunger KG. Ulcerative colitis. Cancer surveillance in an unselec-ted population. Scand J Gastroenterol 1988; 23: 139–145
   PubMed Web of Science ®Google Scholar
• Gyde S N, Prior P, Allan R N, et al. Colorectal cancer in ulcerative colitis: A cohort study of primary referrals from three centres. Gut 1988; 29: 206–217
   PubMed Web of Science ®Google Scholar
• Skinner D B, Walther B C, Riddell R H, et al. Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg 1983; 198: 554–566
   PubMed Web of Science ®Google Scholar
• DeNardi F, Riddell RH. The normal esophagus. Am J Surg Pathol, in press
   Google Scholar
• Reid B J, Lewin K J, Haggitt R C, et al. Endoscopic biopsies can detect high grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 1988; 94: 81–90
   PubMed Web of Science ®Google Scholar
• Skinner D B, Walter B C, Riddell R H, Schmidt H, Iascone C, De MeesterT. Barrett's esophagus: comparison of benign and malignant cases. Ann Surg 1983; 198: 554–566
   PubMed Web of Science ®Google Scholar
• Morson B C, Pang L SC. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 1967; 8: 423–434
   PubMed Web of Science ®Google Scholar
• Collins R H, Feldman M, Fordtran JS. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. N Engl J Med 1987; 316: 1654–1658
   PubMed Web of Science ®Google Scholar
• Blackstone M O, Riddell R H, Rogers B HG, Levin B. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981; 80: 366–374
   PubMed Web of Science ®Google Scholar
• Hammarberg C, Slezak P, Tribukait B. Early detection of malignancy in ulcerative colitis–a flow cytometric DNA study. Cancer 1984; 53: 291–295
   PubMedGoogle Scholar
• Fozard J BJ, Quirke P, Dixon M F, et al. DNA aneuploidy in ulcerative colitis. Gut 1986; 27: 1414–1418
   PubMed Web of Science ®Google Scholar
• Lofberg R, Tribukait B, Ost A, et al. Flow cytometric DNA analysis in longstanding ulcerative colitis: a method of prediction of dysplasia and carcinoma development?. Gut 1987; 28: 1100–1106
   PubMed Web of Science ®Google Scholar
• Melville D M, Jass R J, Shepherd N A, et al. Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis. Gastroenterology 1988; 95: 668–675
   PubMed Web of Science ®Google Scholar
• Rutegard J, Ahsgren L, Stenling R, Roos G. DNA content in ulcerative colitis: flow cytometric in a patient series from a defined area. Dis Colon Rectum 1988; 31: 710–715
   PubMedGoogle Scholar
• McKinely M J, Budsman D R, Gruenberg D, Bronzo R L, Weissman G S, Kahn E. DNA content in Barrett's esophagus and esophageal malignancy. Am J Gastroenterol 1987; 82: 1012–1015
   PubMedGoogle Scholar
• Reid B J, Haggitt R C, Rubin C E, Rabinovitch PS. Barrett's esophagus: Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology 1987; 93: 1–11
   PubMed Web of Science ®Google Scholar
• Rabinovitch P S, Reid B J, Haggitt R C, Norwood T H, Rubin CE. Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab Invest 1988; 60: 65–71
   Web of Science ®Google Scholar
• Fennerty M B, Sampliner R E, Way D, Riddell R, Steinbronn K, Garewal HS. Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus. Gastroenterology 1989; 97: 815–820
   PubMed Web of Science ®Google Scholar
• Riddell R H, Goldman H, Ransohoff D F, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983; 14: 931–968
   PubMed Web of Science ®Google Scholar